| Business Type | Exporter, Supplier, Retailer |
| Color | White |
| Type | Venclyxto Tablet |
| Application | Treatment Of CLL And SLL |
| Click to view more | |
Product Details
Description: Venclyxto contains venetoclax, a BCL2 inhibitor used for treating chronic lymphocytic leukemia (CLL).
\\n
\\n
Contents: Each tablet contains 100mg of venetoclax.
\\n
\\n
Uses: Treatment of CLL and small lymphocytic lymphoma (SLL).
\\n
\\n
How it Works: Induces apoptosis (programmed cell death) in cancer cells by inhibiting BCL2 protein.
\\n
\\n
Directions for Use: Taken orally once daily, gradually increasing dosage as prescribed.Description: Venclyxto contains venetoclax, a BCL2 inhibitor used for treating chronic lymphocytic leukemia (CLL).
\\n
\\n
Contents: Each tablet contains 100mg of venetoclax.
\\n
\\n
Uses: Treatment of CLL and small lymphocytic lymphoma (SLL).
\\n
\\n
How it Works: Induces apoptosis (programmed cell death) in cancer cells by inhibiting BCL2 protein.
\\n
\\n
Directions for Use: Taken orally once daily, gradually increasing dosage as prescribed.
